Cargando…

Propeptide glycosylation and galectin‐3 binding decrease proteolytic activation of human proMMP‐9/progelatinase B

Matrix metalloproteinases (MMPs) are secreted as proenzymes, containing propeptides that interact with the catalytic zinc, thereby controlling MMP activation. The MMP‐9 propeptide is unique in the MMP family because of its post‐translational modification with an N‐linked oligosaccharide. ProMMP‐9 ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boon, Lise, Ugarte‐Berzal, Estefania, Martens, Erik, Vandooren, Jennifer, Rybakin, Vasily, Colau, Didier, Gordon‐Alonso, Monica, van der Bruggen, Pierre, Stöcker, Walter, Becker‐Pauly, Christoph, Witters, Peter, Morava, Eva, Jaeken, Jaak, Proost, Paul, Opdenakker, Ghislain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379967/ https://www.ncbi.nlm.nih.gov/pubmed/30422384 http://dx.doi.org/10.1111/febs.14698

Ejemplares similares

Neutrophils and Activated Macrophages Control Mucosal Immunity by Proteolytic Cleavage of Antileukoproteinase
por: Vandooren, Jennifer, et al.
Publicado: (2018)

MMP-9/Gelatinase B Degrades Immune Complexes in Systemic Lupus Erythematosus
por: Ugarte-Berzal, Estefania, et al.
Publicado: (2019)

Internal Disulfide Bonding and Glycosylation of Interleukin-7 Protect Against Proteolytic Inactivation by Neutrophil Metalloproteinases and Serine Proteases
por: Vandooren, Jennifer, et al.
Publicado: (2021)

EDTA/gelatin zymography method to identify C1s versus activated MMP‐9 in plasma and immune complexes of patients with systemic lupus erythematosus
por: Ugarte‐Berzal, Estefania, et al.
Publicado: (2018)

Glycosylation of matrix metalloproteases and tissue inhibitors: present state, challenges and opportunities
por: Boon, Lise, et al.
Publicado: (2016)

Gelatinase B/matrix metalloproteinase-9 is a phase-specific effector molecule, independent from Fas, in experimental autoimmune encephalomyelitis
por: Ugarte-Berzal, Estefania, et al.
Publicado: (2018)

Gelatinase B/Matrix Metalloproteinase-9 as Innate Immune Effector Molecule in Achalasia
por: Furuzawa-Carballeda, Janette, et al.
Publicado: (2018)

Endotoxemia shifts neutrophils with TIMP-free gelatinase B/MMP-9 from bone marrow to the periphery and induces systematic upregulation of TIMP-1
por: Vandooren, Jennifer, et al.
Publicado: (2017)

Proteolytic Activities of Oral Bacteria on ProMMP-9 and the Effect of Synthetic Proteinase Inhibitors
por: Jie Bao, Guang, et al.
Publicado: (2008)

Thymocyte development in the absence of matrix metalloproteinase-9/gelatinase B
por: Gounko, Natalia V., et al.
Publicado: (2016)

Physiological fibrin hydrogel modulates immune cells and molecules and accelerates mouse skin wound healing
por: Pereira, Rafaela Vaz Sousa, et al.
Publicado: (2023)

How to find and diagnose a CDG due to defective N-glycosylation
por: Lefeber, Dirk J., et al.
Publicado: (2011)

D-galactose supplementation in individuals with PMM2-CDG: results of a multicenter, open label, prospective pilot clinical trial
por: Witters, Peter, et al.
Publicado: (2021)

Proteoform Analysis of Matrix Metalloproteinase-9/Gelatinase B and Discovery of Its Citrullination in Rheumatoid Arthritis Synovial Fluids
por: Grillet, Bernard, et al.
Publicado: (2021)

Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic humaneratinocytes
por: Baumann, P, et al.
Publicado: (2000)

Bivalent Inhibitor with Selectivity for Trimeric MMP-9 Amplifies Neutrophil Chemotaxis and Enables Functional Studies on MMP-9 Proteoforms
por: Nuti, Elisa, et al.
Publicado: (2020)

Chlorite-Oxidized Oxyamylose (COAM) Has Antibacterial Activity and Positively Affects Skin Wound Healing
por: Pereira, Rafaela Vaz Sousa, et al.
Publicado: (2022)

Hypoglycemia in CDG patients due to PMM2 mutations: Follow up on hyperinsulinemic patients
por: Moravej, Hossein, et al.
Publicado: (2019)

Role of N-glycosylation in activation of proMMP-9. A molecular dynamics simulations study
por: Kumar, Sonu, et al.
Publicado: (2018)

Galectin-3, N-terminal Propeptides of Type I and III Procollagen in Patients with Atrial Fibrillation and Metabolic Syndrome
por: Ionin, Valery A., et al.
Publicado: (2020)

Congenital disorders of glycosylation: narration of a story through its patents
por: Monticelli, Maria, et al.
Publicado: (2023)

Cellular uptake of proMMP-2:TIMP-2 complexes by the endocytic receptor megalin/LRP-2
por: Johanns, Manuel, et al.
Publicado: (2017)

Public and patient involvement in needs assessment and social innovation: a people-centred approach to care and research for congenital disorders of glycosylation
por: de Freitas, Cláudia, et al.
Publicado: (2017)

Successful heart transplantation in an infant with phosphoglucomutase 1 deficiency (PGM1‐CDG)
por: Altassan, Ruqaiah, et al.
Publicado: (2022)

Matrix Metalloproteinase-9-Generated COOH-, but Not NH(2)-Terminal Fragments of Serum Amyloid A1 Retain Potentiating Activity in Neutrophil Migration to CXCL8, With Loss of Direct Chemotactic and Cytokine-Inducing Capacity
por: Gouwy, Mieke, et al.
Publicado: (2018)

Congenital Disorders of Glycosylation: A Multi-genetic Disease Family with Multiple Subcellular Locations
por: Jaeken, Jaak
Publicado: (2020)

Differential inhibition of activity, activation and gene expression of MMP-9 in THP-1 cells by azithromycin and minocycline versus bortezomib: A comparative study
por: Vandooren, Jennifer, et al.
Publicado: (2017)

Proteolytic processing of galectin-3 by meprin metalloproteases is crucial for host-microbiome homeostasis
por: Bülck, Cynthia, et al.
Publicado: (2023)

Suramin increases cartilage proteoglycan accumulation in vitro and protects against joint damage triggered by papain injection in mouse knees in vivo
por: Guns, Laura-An, et al.
Publicado: (2017)

Nutritional Therapies in Congenital Disorders of Glycosylation (CDG)
por: Witters, Peter, et al.
Publicado: (2017)

Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants
por: Rossano, Rocco, et al.
Publicado: (2014)

Concomitant elevations of MMP‐9, NGAL, proMMP‐9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary disease
por: Bchir, Sarra, et al.
Publicado: (2016)

Propeptide-Mediated Inhibition of Cognate Gingipain Proteinases
por: Huq, N. Laila, et al.
Publicado: (2013)

Procollagen C-proteinase Enhancer Stimulates Procollagen Processing by Binding to the C-propeptide Region Only
por: Vadon-Le Goff, Sandrine, et al.
Publicado: (2011)

Tspan8 Drives Melanoma Dermal Invasion by Promoting ProMMP-9 Activation and Basement Membrane Proteolysis in a Keratinocyte-Dependent Manner
por: El Kharbili, Manale, et al.
Publicado: (2020)

TGF-β1 facilitates MT1-MMP-mediated proMMP-9 activation and invasion in oral squamous cell carcinoma cells
por: Yamahana, Hirari, et al.
Publicado: (2021)

Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts
por: Sato, T, et al.
Publicado: (1999)

Proteolytic regulation of a galectin-3/Lrp1 axis controls osteoclast-mediated bone resorption
por: Zhu, Lingxin, et al.
Publicado: (2023)

The propeptide of yeast cathepsin D inhibits programmed necrosis
por: Carmona-Gutiérrez, D, et al.
Publicado: (2011)

Dopamine Neuron Stimulating Actions of a GDNF Propeptide
por: Bradley, Luke H., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ri9or9phub354776ivorqgfmsf